Roche Holding AG (LTS:0QOK)
CHF 248.4 1.25 (0.51%) Market Cap: 201.45 Bil Enterprise Value: 231.01 Bil PE Ratio: 18.78 PB Ratio: 6.84 GF Score: 84/100

Roche Holding AG Virtual Analyst Event During ESMO IO Transcript

Dec 10, 2021 / 03:00PM GMT
Release Date Price: CHF377 (+1.07%)
Operator

Ladies and gentlemen, welcome to Roche virtual event on analyst during ESMO IO. My name is Henrik, and I'm the technical operator for today's call. Kindly note that the webinar is being recorded. (Operator Instructions)

At this time, it's my pleasure to introduce you to Karl Mahler, Head of Investor Relations and Group Planning. Karl, the stage is yours.

Karl Mahler
Roche Holding AG - Head of IR

Yes. Thanks a lot, Henrik, for your kind introduction. Welcome to our ninth, actually, science call this year. So 9 events means that we really have lots of news flow -- positive news flow in the case of Roche, and this one is a particularly exciting one despite it's only in a Phase II (inaudible) only in a Phase II. And we have next week our last one in the course of ASH, where we basically testimony our broad and maybe best-in-class portfolio in hematology.

This is the program for today. We will have an updated -- and show to you an updated analysis from the Phase II CITYSCAPE study. Raymond Meng will do that. He is the Global Development Leader

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot